sterofundin has been researched along with Jaundice--Obstructive* in 2 studies
1 trial(s) available for sterofundin and Jaundice--Obstructive
Article | Year |
---|---|
[Infusion correction of bile outflow and endotoxicosis in patients with mechanical jaundice].
The investigations were performed in 139 patients divided into 3 groups and who were given similar volume of infusion therapy (1600 ml/day). In the first group consisting of 54 patients the solution of infusion therapy included the Ringer solution and 10% of glucose solution in the ratio 1:1. In the second group (37 patients) the infusion therapy was performed with a solution of sterofundin-G-5. In the third group (48 patients) remaksol in dose 800 ml/day was included in infusion therapy. The inclusion of sterofundin-G-5 and remaksol in the infusion therapy increased the rate of bile outflow at the early postoperative period as compared with the solutions of Ringer and 10% of glucose. Remaksol is better for arresting endotoxicosis and bile excreting function of the liver as compared with infusion of sterofundin-G-5. Topics: Bile; Bilirubin; Drug Combinations; Female; Glucose; Humans; Infusions, Intravenous; Isotonic Solutions; Jaundice, Obstructive; Liver; Male; Organic Chemicals; Preoperative Care; Ringer's Solution; Succinates; Treatment Outcome | 2011 |
1 other study(ies) available for sterofundin and Jaundice--Obstructive
Article | Year |
---|---|
[Effect of antihypoxant infusion on microbial endotoxin circulation in obstructive jaundice patients].
The dynamics of microbial endotoxemia in group of 149 patients with cholelithiasis complicated by obstructive jaundice has been studied as dependent on the perioperative tactics of infusion therapy. The perioperative period in obstructive jaundice patients is complicated by a significant increase in lipopolysaccharidemia caused by translocation mechanisms and disorders of the liver detoxification function. In Group 1, 47 patients received infusion therapy including Ringer's solution and 10% glucose solution at a 1:1 ratio. In group 2, 55 patients received infusion therapy with only Sterofundin G-5 solution. In Group 3, 47 patients received the infusion therapy with remaxol in a dose of 800 ml/day. It is established that the infusion of Sterofundin G-5, and to a greater extent the infusion of remaxol, reduces the early postoperative degree of decompensation and accelerates recovery of the detoxifying function of Kupffer cells with respect to microbial endotoxin. Topics: Cholelithiasis; Endotoxemia; Fluid Therapy; Glucose; Gram-Negative Bacterial Infections; Humans; Infusions, Parenteral; Isotonic Solutions; Jaundice, Obstructive; Kupffer Cells; Lipopolysaccharides; Liver; Organic Chemicals; Ringer's Solution; Succinates | 2013 |